<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04721574</url>
  </required_header>
  <id_info>
    <org_study_id>2016-05-005</org_study_id>
    <nct_id>NCT04721574</nct_id>
  </id_info>
  <brief_title>Bright Light Therapy on Post-stroke Insomniawith Post-stroke Insomnia</brief_title>
  <official_title>The Effect of Bright Light Therapy on Sleep and Quality of Life in Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Inha University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Inha University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study was to determine the effectiveness of bright light therapy as a&#xD;
      treatment for early, mild-to-moderate stroke patients with post-stroke insomnia.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 1, 2016</start_date>
  <completion_date type="Actual">August 1, 2018</completion_date>
  <primary_completion_date type="Actual">August 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>double-blind, placebo-controlled</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>total sleep duration in actigraphy</measure>
    <time_frame>4 weeks</time_frame>
    <description>the sum [in minutes] of all sleep epochs between sleep onset and sleep end</description>
  </primary_outcome>
  <primary_outcome>
    <measure>sleep onset latency in actigraphy</measure>
    <time_frame>4 weeks</time_frame>
    <description>the interval between time-to-bed and sleep onset</description>
  </primary_outcome>
  <primary_outcome>
    <measure>sleep efficiency in actigraphy</measure>
    <time_frame>4 weeks</time_frame>
    <description>(SE%, the percentage of time spent asleep while in bed</description>
  </primary_outcome>
  <primary_outcome>
    <measure>wake after sleep onset in actigraphy</measure>
    <time_frame>4 weeks</time_frame>
    <description>sum [in minutes] of all awake epochs between sleep onset and sleep end</description>
  </primary_outcome>
  <primary_outcome>
    <measure>number of awakenings in actigraphy</measure>
    <time_frame>4 weeks</time_frame>
    <description>number of awakenings</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>the insomnia severity index</measure>
    <time_frame>4 weeks</time_frame>
    <description>Subjective sleep parameters, 0-28, higher scores indicate more acute symptoms of insomnia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the Pittsburgh Sleep Quality Index</measure>
    <time_frame>4 weeks</time_frame>
    <description>Subjective sleep parameters, 0-21, higher scores indicate more poor sleep quality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Epworth Sleepiness Scale</measure>
    <time_frame>4 weeks</time_frame>
    <description>Subjective sleep parameters, 0-24, 0-28, higher scores indicate more daytime sleepiness</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the Fatigue Severity Scale</measure>
    <time_frame>4 weeks</time_frame>
    <description>Subjective sleep parameters, 0-36, 0-28, higher scores indicate greater fatigue.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Patient Health Questionnaire-9</measure>
    <time_frame>4 weeks</time_frame>
    <description>depression, 0-27, higher scores indicate more severe of depression.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The generalized Anxiety Disorder-7</measure>
    <time_frame>4 weeks</time_frame>
    <description>anxiety, 0-21, higher scores indicate more severe of anxiety</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The World Health Organization Quality of Life Scale Abbreviated Version</measure>
    <time_frame>4 weeks</time_frame>
    <description>overall quality of life through self-reporting, with four subscales in overall health: physical health, psychological health, social relationships, and environmental health. The higher sum in each subscale signified better quality of life.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">56</enrollment>
  <condition>Stroke Sequelae</condition>
  <arm_group>
    <arm_group_label>Bright light therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Daily exposure to a high brightness LED light box for 30 minutes as soon as possible after awakening, preferably between 7 and 8 AM in the patient's hospital room The device emits 10,000 lux of cool-white fluorescent light at 50-75 cm from the screen to the cornea with an ultraviolet filter</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham Therapy</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Light-therapy with filters that reduced lamp output to less than 50 lux. for 30 minutes as soon as possible after awakening.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Philips EnergyUp Energy light HF3418/01</intervention_name>
    <description>high brightness LED light box</description>
    <arm_group_label>Bright light therapy</arm_group_label>
    <other_name>Bright light therapy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Philips EnergyUp Energy light HF3418/01 with filter</intervention_name>
    <description>high brightness LED light box with filters that reduced lamp output to less than 50 lux</description>
    <arm_group_label>Sham Therapy</arm_group_label>
    <other_name>Bright light therapy with filter</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  first occurrence of stroke for the patient&#xD;
&#xD;
          -  matched International Classification of Diseases (ICD)-10 codes (nontraumatic&#xD;
             subarachnoid hemorrhage [I60], nontraumatic intracerebral hemorrhage [I61], other and&#xD;
             unspecified nontraumatic intracranial hemorrhage [I62], or cerebral infarction [I63])&#xD;
             (World Health Organization, 1997)&#xD;
&#xD;
          -  mild-to-moderate stroke (the National Institutes of Health Stroke Scale ≤14)&#xD;
&#xD;
          -  age ≥18 years&#xD;
&#xD;
          -  satisfactory cognitive function&#xD;
&#xD;
          -  post-stroke insomnia.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Mini Mental State Examination (MMSE) score of ≤10&#xD;
&#xD;
          -  recurrent stroke&#xD;
&#xD;
          -  aphasia&#xD;
&#xD;
          -  transient ischemic attack&#xD;
&#xD;
          -  schizophrenia, bipolar disorder, mood disorder, previous insomnia disorder, or&#xD;
             dementia before stroke&#xD;
&#xD;
          -  taking sleeping pills or antidepressants for 5 or more days within a 6-month timespan&#xD;
             before the onset of stroke&#xD;
&#xD;
          -  post-stroke delirium&#xD;
&#xD;
          -  a National Institutes of Health Stroke Scale score ≥ 14&#xD;
&#xD;
          -  previous eye disease or post-stroke eye disease&#xD;
&#xD;
          -  severe auditory impairment&#xD;
&#xD;
          -  the use of psychotropic medications (hypnotics, benzodiazepine, benzodiazepine&#xD;
             agonists, antidepressants [mirtazapine or trazodone] or antipsychotics)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Inha university hospital</name>
      <address>
        <city>Incheon</city>
        <state>Jung-Gu</state>
        <zip>22332</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 18, 2021</study_first_submitted>
  <study_first_submitted_qc>January 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 22, 2021</study_first_posted>
  <last_update_submitted>January 21, 2021</last_update_submitted>
  <last_update_submitted_qc>January 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Inha University Hospital</investigator_affiliation>
    <investigator_full_name>Wonhyoung Kim</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

